Xin Yin Xiaoqing Li Muli Li Qing She Yan Liu Xiaodan Chen Suhua Ma Qian Ma Zhangkan Huang Lin Xu Xiaozhun Huang Zhengyin Zhan Xu Che
10.3389/fmed.2022.891958
Front Med (Lausanne)
2022 May 24;9:891958.
anlotinib extramammary paget disease neuroendocrine differentiation survival tislelizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/35685408/
Case Reports
PMC9170962
35685408
Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature
2022